Related Experiment Video
Updated: Jun 13, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis
Bianca Knoch1, Matthew P G Barnett, Warren C McNabb
1Food, Metabolism and Microbiology Section, Food and Textiles Group, AgResearch Limited, Palmerston North, New Zealand.
Dietary arachidonic acid (AA) did not worsen colon inflammation in a mouse model. Instead, AA reduced ER stress and protected colon cells from oxidative stress, challenging previous assumptions about its role in inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Elevated levels of arachidonic acid (AA), a precursor to pro-inflammatory eicosanoids, are observed in the colonic mucosa of inflammatory bowel disease (IBD) patients.
- The role of dietary AA in modulating colon inflammation and gene expression remains incompletely understood.
Purpose of the Study:
- To investigate the effects of an AA-enriched diet on gene expression profiles in a mouse model of IBD.
- To determine if dietary AA exacerbates or ameliorates colon inflammation and associated molecular pathways.
Main Methods:
- An AA-enriched diet was administered to IL10 gene-deficient (Il10-/-) mice, a model for IBD.
- Gene expression profiles were analyzed using whole genome microarray analysis.
- Comparison was made with Il10-/- mice fed a control oleic acid diet.
Main Results:
- Dietary AA decreased the expression of genes involved in ER stress, complement system, oxidative stress, and acute phase response.
- AA modulated fatty acid metabolism by increasing catabolism and decreasing synthesis gene expression.
- AA was linked to reduced intestinal fibrosis through down-regulation of pro-inflammatory and fibrotic markers.
Conclusions:
- Contrary to the initial hypothesis, dietary AA did not aggravate colon inflammation in Il10-/- mice under the experimental conditions.
- AA demonstrated protective effects by reducing ER stress and oxidative stress in colonocytes.
- Findings suggest a potential anti-inflammatory or protective role for dietary AA in IBD models.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:31Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...